DelMar Pharmaceuticals Announces Pricing Of $9,000,000 Public Offering Of Common Stock And Warrants Apr 14, 2017
Naturally Splendid Develops New HempOmega(TM) Formulations and Appoints Omega Expert to Advisory Board Apr 12, 2017
Naturally Splendid to Launch HempOmega(TM) Fortified Protein Drink at CHFA West Tradeshow Apr 9, 2017
Naturally Splendid Signs Definitive Agreement with Canature to develop HempOmega(TM) Pet Food & Treats Apr 7, 2017
DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting Apr 6, 2017
RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVA® for the Treatment of Cholangiocarcinoma Apr 5, 2017
RedHill Biopharma Announces Exclusive U.S. License from Entera Health for Commercial GI Product EnteraGam® Apr 5, 2017
Positive Results from RepliCel’s RCS-01 Phase I Skin Trial are the Company’s Most Compelling to Date Apr 5, 2017
DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017 Mar 29, 2017
Naturally Splendid to Appear in the Canadian Cannabis Investor Magazine and on the U.S. Cannabis Investor Webcast Mar 29, 2017
RepliCel’s Successful RCT-01 Tendon Repair Clinical Trial Shows Signs of Healing Chronic Tendon Problems Mar 28, 2017
Resverlogix Announces Third Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone and Provides an Update on Corporate Activities Mar 19, 2017
Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office Mar 15, 2017
